Open-House Biologika Discount Contracts 2025-18-Insulin Glargin (Power Strength: 100 U/Ml)

Techniker Krankenkasse Germany has Released a tender for Open-House Biologika Discount Contracts 2025-18-Insulin Glargin (Power Strength: 100 U/Ml) in Pharmaceuticals. The tender was released on Jun 10, 2025.

Country - Germany

Summary - Open-House Biologika Discount Contracts 2025-18-Insulin Glargin (Power Strength: 100 U/Ml)

Deadline - Aug 31, 2027

MT reference number - 110683086

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 110683086

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The targets involved pursue the goal of concluding discount contracts according to Section 130a (8) SGB V with all suitable pharmaceutical entrepreneurs to the active ingredient insulin glargin (effectiveness: 100 u/ml). The conclusion o f the contract takes place as part of the open house biological procedure of the funds involved: Individual negotiations on contract content are not conducted, uniform conditions apply. The health insurance companies involved do not allow individual contractual partners to exclusality. The contract term is a maximum of 24 months starting with the 01.09.2025 (discount launch at the HKK is deviating from 01.10.2025). The contract ends at the latest

Mt Ref Id - 110683086

Deadline - Aug 31, 2027

Share

Similar Tenders :